Location History:
- River Forest, IL (US) (2008 - 2009)
- Chicago, IL (US) (2012)
Company Filing History:
2 out of 2,623 
2 out of 6 
1 out of 11 
Years Active: 2008-2012
Title: **Mark J. Holterman: Innovator in Immunology and Autoimmune Disease Treatment**
Introduction
Mark J. Holterman is an accomplished inventor based in River Forest, Illinois. He has significantly contributed to the field of immunology with a focus on treatments for autoimmune diseases and innovative vaccine development. With a total of three patents to his name, his work continues to influence medical science and improve patient outcomes.
Latest Patents
Mark J. Holterman's recent patents reflect his commitment to advancing healthcare solutions. His first patent discusses "Mutant human CD80 and compositions for and methods of making and using the same," which details improved vaccines and methodologies. Another one focuses on "Immunosuppressive compositions for treating individuals who have autoimmune diseases or transplants," outlining effective methods for patient treatment. Additionally, he has patented "Uses of bispecific antibody coated dendritic cells pulsed with antigens and GM-CSF in immune regulation." This innovative patent reveals that GM-CSF administered prior to immunization can lead to a sustained suppression of myasthenia gravis (MG), highlighting its potential in controlling autoimmune diseases.
Career Highlights
Throughout his career, Mark Holterman has made noteworthy contributions to both academic and industry settings. He has worked at prestigious institutions such as the University of Pennsylvania, gaining insights that have informed his research and inventions. Additionally, he was part of Valorisation-recherche, Société En Commandite, where he further honed his expertise in medical research and technology development.
Collaborations
During his journey as an inventor, Mark has collaborated with several esteemed professionals. Notably, he has worked alongside Michael Agadjanyan, contributing to the growth of knowledge in immunology and fostering innovation in treatment methodologies.
Conclusion
Mark J. Holterman's work exemplifies the spirit of innovation in the medical field. Through his patents, he has made strides in improving treatments for autoimmune diseases and enhancing vaccine efficacy. His collaborative efforts and professional associations continue to inspire advancements that have the potential to transform patient care and medical practices.